Next Article in Journal
Label Noise Learning Method for Metallographic Image Recognition of Heat-Resistant Steel for Use in Pressure Equipment
Previous Article in Journal
Electrode Layout Optimization and Numerical Simulation of Cast Conductive Asphalt Concrete Steel Bridge Deck Pavement
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Iron Oxide-Au Magneto-Plasmonic Heterostructures: Advances in Their Eco-Friendly Synthesis

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
*
Author to whom correspondence should be addressed.
Submission received: 25 July 2022 / Revised: 6 October 2022 / Accepted: 6 October 2022 / Published: 10 October 2022
(This article belongs to the Section Biomaterials)

Abstract

:
In recent years, nanotechnologies have attracted considerable interest, especially in the biomedical field. Among the most investigated particles, magnetic based on iron oxides and Au nanoparticles gained huge interest for their magnetic and plasmonic properties, respectively. These nanoparticles are usually produced starting from processes and reagents that can be the cause of potential human health and environmental concerns. For this reason, there is a need to develop simple, green, low-cost, and non-toxic synthesis methods and reagents. This review aims at providing an overview of the most recently developed processes to produce iron oxide magnetic nanoparticles, Au nanoparticles, and their magneto-plasmonic heterostructures using eco-friendly approaches, focusing the attention on the microorganisms and plant-assisted syntheses and showing the first results of the development of magneto-plasmonic heterostructures.

Graphical Abstract

1. Introduction

In the last few decades, research in the medical sector has been enriched by new approaches based on nanotechnology [1,2], with a particular focus on innovative systems for imaging, drug delivery, cancer therapy, and theranostics [3,4].
In particular, theranostics comprises a combination of diagnosis, therapy, and follow-up of a disease, which takes advantage of the capacity of nanosystems to have both imaging and therapeutic functionalities. Nanoparticles (NPs) have attracted great interest because of the possibility of using them in the field of tumor therapy. They have emerged as key players in modern medicine thanks to their numerous applications in tumor targeting, contrast agents in magnetic resonance imaging, and hyperthermia, as well as in the delivery of therapeutic payloads at tumor sites [5,6]. Both organic and inorganic NPs and their combinations have been proposed as nanocarriers for many therapeutic strategies, providing noninvasive visualization of the targeted tumor (imaging) and carrying multiple theranostic agents.
In particular, the use of magnetic NPs (MNPs) in nanomedicine offers several advantages, both in therapy and in in vitro/in vivo diagnostics [7,8,9], due to the possibility of tailoring their properties by controlling the shape, size, microstructure, synthesis method, stability and surface properties. MNPs are known for their capacity to be directed near the tumor site by magnetic driving without retaining any magnetism after the removal of the magnetic field. They can also be functionalized to carry drugs, nucleic acids, monoclonal antibodies and, viral vectors and are used for diagnostic assays and for the generation of local hyperthermia for tumor therapy.
The potential applications of MNPs in the biomedical field can be further enhanced by their decoration with ultra-small metal nanoparticles, joining the magnetic properties of the core with the optical properties of metal nanoparticles [10,11]. For example, gold NPs (Au NPs) have been the object of several studies due to their surface plasmon resonance (SPR) absorption at visible or near-infrared wavelengths, which make them useful, for example, as photosensitizers in photothermal therapy [12,13]. In fact, they can be externally activated and remote controlled by using a light stimulus. Photothermal therapy mediated by Au NPs is particularly attractive for cancer treatment: the intracellular uptake of Au NPs, which upon irradiation convert absorbed light into thermal energy, produces intracellular heating and disrupts cancer cells, due to their increased heat sensitivity.
The combination of MNPs and Au NPs has been widely exploited to create hybrid nanoplatforms (magneto-plasmonic heterostructures) with several potential applications in biomedicine, such as magneto-photothermal therapy of cancer [14,15]. Usually, the synthesis methods for such hybrid nanoplatforms combine different wet chemistry steps, aimed to induce the nucleation and growth of MNPs and Au NPs, starting from soluble precursors, sometimes using toxic chemicals that can be the cause of potential health and environmental concerns or exposure risks for the operators [16]. The awareness of the need for developing green synthesis approaches to avoid the problems related to synthesis procedures has therefore stimulated a wide range of simple, low-cost and non-toxic approaches [17,18,19].
Given their relevance in theranostics and their collocation in an as yet incomplete area of the study of their production procedures, iron-oxide, and Au nanoparticles, as well as iron-oxide/Au magneto-plasmonic heterostructures, will be the subject of the present review, with a special focus on original green synthesis approaches.
For this research, reviews and papers from the most important publishers were consulted, mainly considering publications in the last 15 years, by searching specific keywords, such as magnetic nanoparticles, Au nanoparticles, green/eco-friendly synthesis, and magneto-plasmonic heterostructures/nanostructures.
This review is divided into three parts: the first one (Section 2) is a brief overview of the magneto-plasmonic heterostructures that can be developed, the second part (Section 3), gives the reader a concise review of the main applications of magneto-plasmonic heterostructures in the biomedical field, the third part (Section 4) is dedicated to the description of eco-friendly approaches to developing magnetic (based on iron-oxides) and plasmonic (Au) nanoparticles, and to the illustration of the first green attempts to the design of magneto-plasmonic heterostructures. The review concludes by providing some indications for prospective research and future challenges in the field.

2. Overview of Magneto-Plasmonic Heterostructures

The magneto-plasmonic nanostructures based on iron oxides and gold nanoparticles are mainly divided into two categories: the FAuNSs (Fe3-xO4-Au nanostructures), which consist in a magnetic core on whose surface Au NPs or Au coating are attached or the AuFNSs (Au-Fe3-xO4 nanostructures) constituted by a single or multiple Au cores, surrounded by a Fe3−xO4 coating [14]. The magnetic properties of nanostructures are determined by the synthesis method, the chemical composition of the magnetic fraction (e.g., pure magnetite nanoparticles or a combination of magnetite/maghemite nanoparticles), their size and their morphology/architecture (e.g., single core, multicore, clusters) [20,21,22]. Regarding the properties of plasmonic nanoparticles, they can be modulated by tailoring the shape of the gold component [14,15,23,24], from a continuous thin layer (spherical or not spherical) to small Au particles.
The main features of FAuNSs are the aptitude to be easily conjugated with different biological moieties due to Au NPs surface ability to be functionalized with thiol groups, the affinity of Au surface for different electron-donating groups, several hydrophilic ligands and polymers [25,26], enhancing the functionality of magnetic NPs. Moreover, the gold NPs/coatings protect the nanostructures from chemical oxidation, confer them stability by preventing the nanostructures agglomeration and flocculation, and improve their biocompatibility. With regard to AuFNSs, these structures normally have important magnetic properties, due to the spin alignment at the gold/iron oxide interface and the dipolar interactions between one AuFNS and another.
Both FAuNSs and AuFNSs can be mainly divided into different categories on the basis of their structures:
(a)
Core-satellites: in FAuNSs iron-oxide nanoparticles, single or multicore, can be surrounded by small Au NPs grafted on a magnetic particles surface, or an inorganic (e-g, silica) or organic shell (including small organic molecules or surfactants, polymers, and biomolecules) can be inserted between magnetic and plasmonic structures. Alternatively, a nanodumbell structure can be obtained. In AuFNSs, a gold nanoparticle is surrounded by several magnetic small particles [10,27];
(b)
Spherical core-shell: in this case, a magnetic core (single or multicore) is coated with a thin layer of gold or gold and an intermediate layer (FAuNSs); in contrast, a single gold nanoparticle can be coated by a magnetic shell, which possesses high magnetization [28,29,30];
(c)
Non-spherical core-shell: both FANSs and AFNSs can be also obtained by coating non-spherical Au/iron oxide non-spherical particles (e.g., rods, stars or flowers). The non-spherical shape can affect the optical and magnetic properties of the nanostructures. For example, Au nanorods possess an absorption peak shifted to the NIR region, compared to Au nanoparticles [31,32,33];
(d)
Hollow structures: they are mainly composed of a core of iron oxide and a shell of gold. Between the magnetic core and the shell there is an empty space, which confers a very high specific area and reactivity to the nanostructures. Moreover, these hollow structures possess unique optical and magnetic properties and the hollow space can be used to load drugs [34,35].
Figure 1 shows a scheme of the possible magneto-plasmonic structures (FAuNSs and AuFNSs).

3. Main Applications of Magneto-Plasmonic Heterostructures in the Biomedical Field

3.1. Photothermal Therapy (PTT)

PTT is a therapy that consists in exploiting light radiation in the visible (Vis) or near-infrared (NIR) region to produce heat in a specific target region of the body, in order to induce cancer cells apoptosis and kill them (Figure 2a). Due to the well-known SPR effect, gold nanoparticles can be irradiated with laser light having a specific wavelength, transforming the radiation into thermal energy, thus producing heat, which induces tumoral cells in apoptosis [36,37]. Au NPs are widely investigated since they possess million times higher absorption capacity than conventional dye molecules, they are photostable, biocompatible, and have a high conversion efficiency of the absorbed light into heat. Their great conversion efficiency allows some of the most common problems of conventional organic dyes to be overcome, such as the photobleaching phenomenon, to which organic dyes are subjected, and the low absorption efficiency [38].
One of the main advantages of PTT is the use of light as an external stimulus, since it is easy to regulate, focus, and remotely control using a pulsed or continued wave laser. The employment of laser light as a source and the connected benefits allow a better tumor-targeted treatment, preserving healthy tissues from damage since tumoral cells and tissues have higher heat sensitivity in comparison with healthy ones [39,40]. The heat produced by nanostructures, which should be between 43 °C and 46 °C, alters the functions of the tumoral cells, causing their destruction through apoptosis. Furthermore, the tumoral tissue is poorly vascularized and thus the temperature rises higher than in the surrounding well-vascularized or normal tissues. Hyperthermia can also kill hypoxic cells that are radiation resistant, both directly, as a function of the reached temperature and the heating period, or indirectly, increasing blood flow and thus improving tissue oxygenation, and radio-sensitizing via DNA repair inhibition. Moreover, Au NPs can also be functionalized with specific target ligands useful for focalizing the treatment at the tumor site [41].
The coupling of Au nanoparticles with iron oxide nanoparticles allows the PPT to be combined with the magnetic features of iron oxide NPs. Moreover, recent studies reported that the use of a magnetic field can cause a reversible aggregation of nanostructures with an enhancement of the surface-enhanced Raman spectroscopy signal (SERS), a shift of their plasmonic absorbance, and an increase in the efficiency of the NIR-induced PTT/photothermal effect [42,43,44,45].

3.2. Magnetic Hyperthermia

Magnetic iron oxide nanoparticles, and in particular Fe3O4 NPs, have been widely investigated and applied in biomedical applications, due to their biocompatibility and the possibility of functionalizing them or coated them with different chemical and biological species [46,47].
Magnetic nanoparticles, when subjected to an alternating electromagnetic field, possess the ability to convert electromagnetic energy into thermal energy due to magnetic losses, and thus they can be used in the hyperthermia treatment of tumors [48,49] (Figure 2b).
Hyperthermia can directly kill cells, leading to a loss of cellular homeostasis by protein denaturation and aggregation and the increase in reactive oxygen species [50]. Several studies have also shown that hyperthermia treatment enhances the effects of chemotherapy and radiotherapy, reducing their side effects [51,52,53,54,55,56,57,58,59]. Moreover, it has been demonstrated that hyperthermia can kill hypoxic cells and cells that are in the S phase, which are resistant to radiotherapy [56].
Their ability to release heat depends on the particles size, shape, and coercivity as well as on the power and frequency of the used alternating magnetic field [60]. Also, the aggregation state can influence the nanoparticles’ ability to release heat, as reported in [61]. Finally, the use of the magnetic field as a stimulus allows the use of hyperthermia, even in deep tissues [48,62].
Magnetic nanoparticles have been also proposed as a therapeutic system in conjunction with hyperthermia. The application of an alternating magnetic field can favor the release of drug molecules attached to the magnetic NPs surface by a linker. The developed heat can cause the degradation of the linker molecule, promoting the release of the drug, and simultaneously kill cancer cells that are sensitive to heat [63]. By tailoring the intensity and frequency of the applied electromagnetic field, it is possible to modulate the drug release kinetics and combine it with hyperthermia.
The opportunity of creating magneto-plasmonic heterostructures allows combining the magnetic hyperthermia and the unique properties of plasmonic particles (e.g., SERS application, easy functionalization), thus designing technological nanomaterials for diagnosis and therapy.

3.3. Drug Delivery and Targeting

Drug delivery consists in the distribution of substances and drugs in a specific area of the human body affected by a disease or a tumor. This process is more specific and effective than systemic administration and allows side effects on the healthy tissues to be limited, and to reduce the necessary dosage.
The process basically consists in the injection of magneto-plasmonic nanoparticles in the body area affected by a tumor, or alternatively, the nanostructures can be intravascular injected and magnetically guided at the tumor site. Once reached, the desired location, the drug/bioactive agent can be released in a controlled manner using an external magnetic field or through changes in physiological conditions such as pH, temperature, or osmolality [64]. Ideally, a drug delivery system should contain the maximum drug load and release it at the desired site with detailed kinetics in function of the envisaged disease. For this reason, the dimensions, the charge, and the surface chemistry of the nanoparticles are particularly important features in this application as they strongly influence the circulation time in the body through the blood vessels. Generally, the optimal diameter range for this application is around between 10 and 100 nm; in fact, smaller nanostructures can be easily expelled through kidney cleansing, while the upper limit is not well defined, and it can be set according to the type of tumor into which the nanoparticles must penetrate, and the administration route.
Magneto-plasmonic nanoparticles adopted in drug delivery and targeting often consist in hollow nanostructures, due to the chance of physically entrapping drugs/bioactive agents in their hollow interior [64]. Differently, both magnetic and gold NPs could be functionalized with different targeting molecules and act as drug delivery systems in order to deliver and locally release therapeutic substances to destroy specific cells (Figure 2c). Magnetic nanoparticles used as a controlled delivery system are often functionalized or coated with biocompatible responsive polymers, able to encapsulate large amounts of drugs, and silica, which shows many -OH groups useful for further functionalization, or mesoporous silica, which presents a highly controlled porosity useful to adsorb drugs [65]. Even gold nanoparticles can easily be functionalized with high-affinity moieties (e.g., ligands) able to detect cells or tissues in a selective way; they can accumulate in diseased tissues and release their payload directly on the target site, thus reducing the drug dose administered, and limiting undesirable absorption into healthy tissue and consequent side effects [66]. One of the advantages of using Au NPs as drug carriers is provided by their simple synthesis methods, involving the use and functionalization of specific chemical species on the surface of the Au NPs. These molecules form a shell that covers and stabilizes the particles and at the same time provides binding sites (such as free–SH groups) to which various other payloads can be easily attached.
Therefore, the functionalization of magneto-plasmonic heterostructures can both allow the systemic distribution of drugs by reducing their related side effects and decrease the required dose for the treatment.

3.4. Bioimaging

Superparamagnetic nanocrystals of iron oxides can be used as contrast agents in magnetic resonance imaging (MRI), a non-invasive imaging technique used in the medical field to discriminate different tissues on the basis of their biochemical composition [67]. MRI is based on the nuclear magnetic resonance of the protons of the water present in the body. Tumors and diseased cells can be detected due to the different return rate to the original magnetization situation by protons placed in different tissues; this effect is used to create a contrast between different types of tissue in the body. By using magnetic nanoparticles, the resolution of MRI images greatly increases, allowing the identification of diseases or tumoral areas, which cannot be detected by other techniques.
In particular, iron oxide-based magnetic particles (eventually coated by a gold shell), thanks to their ability to significantly reduce transverse relaxation times, are studied and approved by the FDA as T2 contrast agents for magnetic resonance imaging [68,69]. Moreover, due to their physiochemical properties, iron-oxide nanoparticles are recently investigated as T1 contrast agents; preclinical studies using superparamagnetic iron oxides as an alternative to Gd3+-based contrast agents are ongoing [70,71].
Recently, the use of magnetic nanoparticles in magnetic particle imaging (MPI) has also attracted considerable attention [67,72]; this modality is currently used in the preclinical field and does not use nanoparticles as a contrast agent but as a tracer. In MPI, the magnetic particles, in particular those based on iron oxide, are subjected to an oscillating magnetic field generating a signal derived from their non-linear magnetization [73]. The technique can provide four-dimensional information on the spatial distribution of NPs and quantifies their concentration with resolution; several studies have been carried out at a pre-clinical level for different biomedical applications, including cancer tracing and the MPI guidance of magnetic fluid hyperthermia [72].
With regard to Au nanoparticles, their specific optical properties from the wavelengths of visible light to NIR, thanks to the high electron density of gold, can be used as nanosources in optical imaging, or in optical coherence tomography, computed tomography, dark field microscopy and photoacoustic imaging [14].
Due to the high scattering properties and the high photostability, if compared with other dyes, Au NPs have emerged as an extremely promising tool for cellular imaging and monitoring. The scattering ability of Au NPs depends on their size and shape; different studies report a suitable Au NPs size range between 20 and 100 nm [74]; their strong emission power makes them easily detected and so they are a promising tool for cancer cell imaging (Figure 2d).
By combining the characteristics of plasmonic and magnetic nanoparticles, more precise diagnoses can be obtained, as the integration of these nanostructures allows the respective strengths to be combined and eliminates the critical aspects, such as the low sensitivity of the magnetic resonance, which is compensated for by the plasmonic NPs.

3.5. SERS Application, Detection and Separation

For the selection and separation of biological and chemical molecules, the most commonly used method is Surface-Enhanced Raman Spectroscopy (SERS). As evidenced by several studies [75,76,77,78], the use of plasmonic nanoparticles, in particular Au NPs for their high chemical stability and their SPR support in the visible region, can significantly improve the SERS signal both in vitro and in vivo.
The combination of plasmonic nanoparticles with magnetic nanoparticles allows for the concentration and the potential separation of analytes, achieving high sensitivity targeting. The concentration and aggregation of nanostructures also allow for the creation of hot spots, which increase the intensity of the SERS and thus promote sensitivity. Moreover, the magnetic component can be exploited for immobilizing the nanoparticles on a solid substrate.
For these reasons, magneto-plasmonic heterostructures are often investigated for the detection and isolation of low concentrated small molecules, such as nucleic acids or proteins, as reported in [79,80,81,82], or for the detection and isolation of pathogens, such as bacteria and virus, both directly or indirectly, using specific antibodies [83,84,85,86] (Figure 2e).

4. Green Synthesis Methods of Magneto-Plasmonic Heterostructures

The syntheses of iron oxide or gold nanoparticles, as well as the development of hybrid iron oxide–gold heterostructures are often hazardous and expensive, involve the use of harmful chemicals and sometimes toxic reducing and dispersing agents that lead to biological risks and the formation of environmentally pollutant coproducts [87,88].
Several methods for the synthesis of magnetic and plasmonic nanoparticles, as well as magneto-plasmonic heterostructures, have been reported in the literature, including co-precipitation technique, thermal decomposition, solvothermal method, Brust’s method and flame aerosol synthesis [89,90]. However, these chemical and physical syntheses of nanostructures present numerous issues, mainly due to the use of toxic chemicals during the process steps, which could limit their use in medical field. For these reasons, there is an essential need to develop easier, environmentally friendly and cost-effective procedures for nanoparticles synthesis suitable for large scale production.
In recent years, the biological synthesis of nanoparticles and nanostructures has been proposed as a new approach and has attracted great attention [91,92,93]. This new ecological approach for the synthesis of nanostructures presents various advantages such as simplicity, cost-effectiveness, compatibility for biomedical and pharmaceutical applications, as well as large-scale commercial production. A promising approach for achieving this goal is to exploit the wide range of biological resources. In fact, over the last few years, plants, algae, fungi, bacteria and viruses have been used for metallic NPs production with low-cost, low-energy dissipation and non-toxic method [93].
The synthesis and assembly of nanostructures would benefit from the development of clean, non-toxic and environmentally friendly technologies that go under the name of “Green Chemistry”. Green chemistry aims to use less or avoid using hazardous substances in a chemical process. In fact, green chemistry is a movement to find alternatives to the use of hazardous chemicals such as feedstock, reagents, solvents, products, and byproducts in the production processes. Moreover, it is concerned with the sustainability of using raw materials and energy sources for manufacturing [93].
The use of Green Chemistry in nanosciences allows high precision in the synthesis and low production of waste to be achieved, which are enormous benefits in production on a commercial scale, for society and the environment [94]. The use of low-cost chemicals, non-toxic and biodegradable solvents is essential for the synthesis of non-dangerous materials for both the environment and humans. Several metal and non-metal nanoparticles can be obtained by the biochemical processes in biological agents, by means of rapid procedures in comparison with chemical routes. Moreover, some of the eco-friendly components can be used as both reducing, capping, and stabilizing agents, limiting the use of further agents and accelerating the synthesis of the nanostructures [95]. The reducing agent, the reaction medium, and the stabilizing agent are the three key factors for the synthesis and stability of nanoparticles also in biological synthesis [95,96]. In particular, during the synthesis of nanoparticles by means of microorganisms and plant extracts, several process parameters should be carefully controlled to obtain stable and dispersed nanoparticles, such as the temperature, the pH of the medium, the reaction time, and the mixing ratio.
Although the complete synthesis of magneto-plasmonic nanostructures through green processes is still poorly investigated, several studies have focused on the biological and eco-friendly synthesis of magnetic or plasmonic particles. The following paragraphs summarize the most important concepts concerning the synthesis of magnetic and plasmonic nanoparticles (Au) using microorganisms, plants extract/derivatives and other green materials (e.g., enzymes, vitamins, polysaccharides, and amino acids, etc.).

4.1. Microorganism-Assisted Synthesis of Iron Oxide and Au NPs

A broad range of microorganisms, such as bacteria, cyanobacteria, fungi, mycetes, yeast, and algae, have been investigated as potential nanofactories for the production of inorganic nanoparticles, avoiding the use of toxic reactants and the requirement of high energy. The precise mechanisms by which bacteria synthesize nanoparticles are not yet fully understood. However, it seems that the pathways of defense response and the different reductase enzymes contained in the bacterial cell wall (e.g., NADPH-dependent reductase, cytochrome oxidase, phosphoadenosine phosphosulfate reductase, sulfite reductase, fibrinolytic enzymes, and hydrogenase) are responsible for the synthesis of inorganic nanoparticles, such as gold, iron, silver, lead, titanium oxide and iron oxide [95,96,97]. Table 1 summarizes the main investigative studies concerning the microorganism-assisted synthesis of iron oxide-based and Au nanoparticles. The syntheses of NPs mediated by microorganisms, besides being eco-friendly, are also cost-effective, due to the abundance of microorganisms in different environments. Moreover, the syntheses are easily controllable from the chemical and physical points of view. The microorganism-assisted synthesis can be performed both intracellular or extracellular; in the intracellular process, the positive precursor ions are transported inside the cell wall, which is negatively charged. Ions then diffuse through the cell wall by electrostatic attraction and are reduced by the enzymes present in the cell walls. In the extracellular mechanism, metal ions are trapped on the surface of the microorganisms, which can exchange electrons with extracellular environments, and they are reduced in the presence of some enzymes (e.g., nitrate reductase or hydroquinone).
Among the different nanoparticles obtained using microorganisms, monodispersed iron-oxide-based magnetic NPs, which possess high purity, little crystalline defects, and narrow size, have been also developed [98,99,100,122]. Iron-oxide NPs can be produced extracellularly (biologically induced biomineralization) or intracellularly (biologically controlled biomineralization); the second route allows more ordered crystalline nanoparticles to be obtained, having a narrow size distribution and controlled morphology.
As an example, the extracellular method was adopted by Majeed et al., who developed well-dispersed Fe3O4 nanoparticles (20–30 nm in diameter) using Proteus vulgaris [98]. The nanoparticles obtained showed a good antibacterial effect towards methicillin-resistant Staphylococcus aureus (MRSA) and antioxidant activity. Moreover, the NPs demonstrated high cytotoxicity against U87 MG—glioblastoma cancer cells and less toxicity towards the normal L-132 cells, proving that microbiologically synthesized nanoparticles are safe and eco-friendly. In another study, intracellular, cost-effective, and monodispersed (due to the protein sheaths that acted as naturally surface stabilizing agents) magnetite NPs were produced using different clinically isolated Pseudomonas aeruginosa strains (named SKP1, SKP32, SKH16, and SKH21), a magnetotactic bacterium [100]. The results obtained (Figure 3) evidenced the formation of biocompatible, well-dispersed magnetic nanoparticles, ranging in size from 35 to 50 nm in diameter. Among other bacteria, investigated as magnetic nanoparticles reducing agents, we can mention: Thermoanaerobacter ethanolicus, Magnetospirillium magnetotacticum, and Shewanella sps. [100,101]. The features of the obtained nanoparticles, as well as the type of bacterium, depend on different parameters, such as the pH of the culture medium, environmental parameters, the temperature, and the redox potential. Moreover, the use of magnetotactic bacteria, cells able to intracellularly mineralize nano-sized inorganic magnetic crystals [123], allows other chemical reagents not to be used, and therefore it is, among the mentioned approaches, a completely green method.
Fungi have also been used for the production of iron oxide nanoparticles [58,59]. They can easily be handled in the laboratory, possess high metal tolerance and secrete a large quantity of enzymes. Compared to bacteria, therefore, they are capable of producing nanoparticles on a larger scale [124]. As an example, Bharde et al. synthesized magnetite nanoparticles using both Fusarium oxysporum and Verticillium sp. starting from ferric and ferrous salts [102] in acidic conditions. The use of Fusarium oxysporum allowed pseudo-spherical magnetite NPs to be synthesized in the size range from 20 to 50 nm, while cubo-octahedrally shaped magnetite NPs between 100 and 400 nm were obtained using Verticillium sp. Both the nanoparticles obtained exhibited signatures of a ferrimagnetic transition with a negligible amount of spontaneous magnetization at room temperature. The protein analysis suggested that the cationic proteins secreted by the fungi are responsible for the cellular hydrolysis of the anionic iron complexes and the capping of magnetite nanoparticles. Thus, the ability of fungi to hydrolyze iron metal demonstrated the huge potential for the development of eco-friendly and large-scale syntheses of magnetic iron-oxide-based nanoparticles. In another study [103], spherical Fe3O4 nanoparticles together with pure Fe nanoparticles (between 9 and 50 nm) were prepared using the fungus Aspergillus niger and supercritical condition methods. The particles obtained possessed a saturation magnetization of 112 (Fe) and 68 emu/g (Fe3O4), allowing their use in different biomedical applications such as hyperthermia and contrast agent.
Plasmonic NPs, such as Au and Ag, have been also produced using microorganisms both intracellularly and extracellularly [125,126,127]. Several bacteria, such as Caldicellulosiruptor changbaiensis, Shewanella loihica, Micrococcus yunnanensis, Stenotrophomonas maltophilia, Actinobacterspp Rhodopseudomonas, P. aeruginosa, Bacillus, Escherichia coli and Klebsiella pneumoniae [104,105,106,107,108,109,110,111,112,113], fungi, among them Alternaria alternate, Fusarium oxysporum, T. koningii, Hormoconis resinae, Aureobasidium pullulans, Fusarium, Phanerochaete Chrysosporium and Botrytis cinerea [114,115,116,117,118,119,128], and algae [120,121] have been investigated as a Au-nanoparticle-reducing agent. To give some examples, recently Jafari and co-authors [106] used the Micrococcus yunnanensis J2 strain to biosynthesize Au NPs, which possessed anticancer activity towards six cancer cell lines and an antibacterial effect against both Gram-positive and negative strains. He et al. [109] used Rhodopseudomonas capsulate as green approach to synthesize Au NPs with different sizes and shapes, highlighting as an important parameter for the synthesis of inorganic nanoparticles mediated by bacteria the pH of the medium. By adjusting the pH medium at 7, they obtained spherical Au NPs with a diameter in the range of 10–20 nm. Concerning fungi-mediated synthesis, it is an economic, easy and scalable process to produce Au NPs, due to their bioaccumulation ability and the chance to produce a large number of extracellular enzymes responsible for the reduction process. For example, Sarkar et al., produced Au NPs by the reduction of chloroauric acid using Alternaria alternate [114]. The Au NPs showed different shapes, an average particle size of 12 nm and they are coated with a protein shell that enhances their stabilization. In another study, Au nanoparticles with different shapes (triangular, hexagonal, spherical, decahedral, and pyramidal) and dimensions (from 1 to 100 nm) were extracellularly obtained [119] by means of the reduction of chloroauric acid mainly due to Botrytis cinerea NADH-dependent reductase activity. Furthermore, as evidenced in the study by Mishra et al. [129] the use of Penicillium rugulosum, allowed uniform Au NPs to be synthesized much more easily than bacteria and yeast-mediated synthesis.
Algae-mediated synthesis has been also explored, due to algae’s ability to accumulate heavy metals, secrete fucoidans (polysaccharides able to reduce metal NPs), and since they are characterized by different functional groups useful for the uptake (e.g., carboxyl groups) [127].
As mentioned above, the formation of nanoparticles mediated by microorganisms in the different studies was achieved through two approaches: the interaction of metal ions with surface proteins or biomolecules present on the cell membrane and their reduction through the interaction with the extracellular content or secretome of the organisms. Both methods allow nanoparticles of fairly controlled shape and size to be obtained.

4.2. Plants/Derivatives Assisted Synthesis of Iron Oxide and Au NPs

Plants extracts and their derivatives have also been extensively studied and used in literature to synthesize nanoparticles. Even if a comparison is complicated, usually the synthesis of nanoparticles starting from plants/derivates extracts is an even simpler and more reproducible process than the synthesis mediated by microorganisms [130]. In particular, the synthesis of metal nanoparticles, such as Au, is extensively investigated in the literature, while the realization of metal oxide NPs, including magnetic particles based on iron oxides, is less explored, but there are still several studies on the subject.
As microorganisms, plants are easy to handle, harmless and economic. (They can also be recovered from production waste, promoting a circular economy). The plant-assisted syntheses can be carried out using distinct parts of the plant (e.g., leaves, seeds, and flowers, etc.), extracts or derivatives, rich in compounds (e.g., amino acids, polyphenols, and reducing sugars), and they often act as both reducers and stabilizers or capping agents [131,132,133,134]. Plant-mediated synthesis often concerns the preparation of an extract by washing the plant (or part of the plant) in water or other solvents, cutting it into small pieces, boiling it in distilled water, and purifying the extract with different methods, such as filtration and centrifugation. The main parameters that can affect the synthesis, the quantity of NPs obtained, as well as their shape and size, are of course the plant type, the extract/derivate concentration, proteins present in the extract, the temperature, the pH of the medium, the electrochemical potential, the NPs precursors and the incubation time. Moreover, plant-assisted synthesis has the advantage of providing faster synthesis compared to the microorganism-assisted process.
There are two chief mechanisms involved in the synthesis of nanoparticles through the use of plants or derivatives [135]: (i) the reduction of metal ions by the surface of the proteins, due to the strong electrostatic attraction between the ions and proteins of the plants/extracts; (ii) the reduction of metal ions by various active components, among which are enzymes, vitamins, amino acids, polysaccharides, polyphenols, flavonoids and organic acids, which, in addition to forming nanoparticles, encapsulate them, preventing their agglomeration. This second hypothesis seems to be the most accepted in the literature.
Recently, iron-oxide NPs have been synthesized using different plant extracts/derivatives, such as green tea leaves, Solanum trilobatum, Ziziphora tenuior, Persia americana, Abutilon indicum, Azadirachta indica, Camellia sinensisù, Curcumin, Carica papaya, Aloe vera, Flaxseed, Pistachio Leaf, Carob pod, Cynara cardunculus, Citrus limon and many others [131,136,137]. The syntheses often lead to stable and well-dispersed nanoparticles with a controlled morphology. Moreover, by varying the synthesis parameters, particles with a specific shape (such as spherical, cubical, cylindrical, needles, and prisms, etc.) and features can be obtained [131]. Spherical magnetite-based nanoparticles, ranging from a few nm to a thousand nm have been obtained using several plant extracts. For example, Yew et al. synthesize spherical magnetite NPs with an average size of 14.7 nm using Seaweed Kappaphycus alvarezii as a green reducing and stabilizing agent [138]. In another study [139], Fe3O4 nanoparticles have been synthesized using leaves of Platanus orientalis L. plant and starting from ferric and ferrous chlorides. The average size of the nanoparticles obtained was about 35 nm. They were quasi-spherical and presented high purity and crystallinity, and can potentially be used in the biomedical field. Kanagasubbulakshmi and co-authors also used Lagenaria siceraria leaves extract to prepare cubic Fe3O4 NPs (20–100 nm) [140]. The synthesized NPs showed different functional groups on their surface (–OH and –COOH), which afford them hydrophilicity and they can be used for further functionalization. Moreover, they possessed antimicrobial activity towards both Gram-positive and negative strains.
Obviously, also Au nanoparticles for different application fields, including the biomedical one, have been produced by means of plant-mediated synthesis [132,133,134,135,141,142,143]. The first authors to report the synthesis of gold nanoparticles using plants were Gardea-Torresdey and co-workers in 2002 [144]. As for magnetic NPs, different plant types and extracts have been investigated, among them Pelargonium graveolens, Euphrasia officinalis, Ziziphus zizyphus, Indigofera tinctorial, Curcumin, Mussaenda glabrata, Olax scandens, Panax ginseng, Nerium oleander, Ananas comosus, Lippia citriodora, Mangifera indica, Salvia officinalis, Pelargonium graveolens, Punica granatum, mango peel, and potato starch [135,141,142,143]. To mention some examples, one of the first optimized studies for the production of Au NPs from plants was carried out by Daizy Philip and co-authors [145]. They obtained spherical and stable Au NPs of about 20 nm in diameter in 2 min of HAuCl4 incubation with Mangifera indica extract. Moreover, they identified some soluble compounds such as flavonoids, terpenoids, and thiamine as capping ligands of Au nanoparticles. More recently, Aljabali et al. produced environmentally friendly monodispersed Au nanoparticles, starting from the leaf extract of Ziziphus zizyphus [146]. The nanoparticles obtained are almost spherical with an average diameter of 40–50 nm. They are biocompatible and are capped with several biomolecules, present in the plant extract, having antioxidant properties and useful for further functionalization steps (Figure 4). Spherical Au NPs have been also obtained using Curcumin [147] as a reducing and capping agent. The synthesized NPs exhibited antibacterial, antioxidant, and radical scavenging activities, demonstrating once again the potential of nanoparticles formed by using plants in the biomedical field. Also, non-spherical Au NPs have been obtained from plant extracts, for example Ahmad et al. synthesized hexagonal and triangular Au NPs in addition to the spherical ones, using Trapa natans peel extract [148]; while Geethalakshmi and co-authors developed spherical, triangular, hexagonal and cubical Au NPs (33–65 nm) with antimicrobial properties by means of the Trianthema decandra root [149].
Au NPs produced using mango peel extract have been reported by Yang et al. [150]; authors demonstrated that the use of mango peel extract allowed cytocompatible (up to 160 μg·mL−1) monodispersed Au NPs to be synthesized in the range 6.03 ± 2.77–18.01 ± 3.67 nm. They also demonstrated that the reaction rate was significantly faster than other plant extracts.

4.3. Other Green Reducing Agents

A last eco-friendly approach to synthesizing nanoparticles is the direct use of green compounds (e.g., polysaccharides, natural polymers, and amino acids, etc.) to reduce metal salts [151]. Several studies reported the synthesis and stabilization of nanoparticles (including magnetic iron-oxide and gold NPs) by means of biomolecules or green active ingredients, such as heparin [152,153], glucose [154,155,156], gallic acid [157,158,159], tannic acid [159,160,161] and starch [162,163,164].
As an example, iron-oxide NPs have been produced using both tannic and gallic acid [159]; both tannins produced NPs with a size <10 nm at basic pH. The presence of the phenolic -OH groups in tannins allowed for a facile synthesis of iron-oxide NPs and supported their stabilization, avoiding the formation of aggregates.
Instead, a “clean” method for synthesizing gold and silver NPs involved the use of HAuCl4, which undergo reduction with heparin and hyaluronic acid, which are reducing and stabilizers agents [152]. The NPs thus obtained show stability under physiological conditions and have important biological activities (such as anti-inflammatory and anticoagulant efficacy) demonstrated by in vivo and in vitro studies. Gorges and co-workers used glucose as a reducing agent to form Au NPs using chlorinated ions trapped in a film of amines and lipids in turn trapped on a glass substrate [154].

4.4. Green Synthesis of Magneto-Plasmonic Heterostructures

Combining magnetic and plasmonic properties in a single particle can bring useful synergy for several biomedical applications, such as contrast improvement in new magnetomotor imaging modalities, the concurrent capture and detection of circulating tumor cells, and molecular imaging multimodal combined with photothermal therapy. Up to now the green syntheses of iron oxides-based magnetic nanoparticles or gold plasmonic particles have been described. A completely green synthesis of composite nanostructures (heterostructures), according to the authors’ knowledge, has not yet been developed. However, in the literature, there are several studies in which at least one of the two nanoparticles or part of the synthesis process has been carried out using a green approach [11,165,166,167,168,169,170,171,172,173,174].
Concerning the biomedical field, the authors recently proposed a green approach to develop magneto-plasmonic nanoparticles for photothermal therapy, using tannic acid or gallic acid as a green reducing agent [11,165,166]. They produced superparamagnetic iron oxide nanoparticles by co-precipitation method and subsequently, they used tannic acid to reduce in situ the Au nanoparticles on the surfaces of the magnetite obtained [11]. The hybrid nanoplatforms obtained are composed of a magnetic core and an external Au NPs decoration, forming a sort of nano-dumbbell (Figure 5). The biological characterization evidenced the nanoplatform’s ability to selectively damage cancer cells (HO-1-N-1), preserving the healthy ones (HGF) upon irradiation with a 530 nm continuous wave laser light. The authors then evaluated the influence of magnetic NPs functionalization and the different sequences of addition of tannic acid on the shape and dimensions of the composite nanoparticles [11]. They observed that the APTES functionalization of magnetic NPs can improve the grafting of Au NPs and the APTES concentration can tune the shape and dimensions of nanoplatforms, as well as the concentration of tannic acid. Moreover, in order to guide the nucleation and growth of Au NPs on magnetic NPs surface, the sequence of the addition of the Au NPs precursors and reducing agent plays a fundamental role in the shape of nanoplatforms and then in the magneto-plasmonic properties. Other authors proposed the use of tannic acid as a green reducing agent to obtain a hybrid material composed of Au NPs deposited at the surface of CoFe2O4, even if for different applications. In this case, the authors evidenced an efficient Au deposition on CoFe2O4 core functionalized with APTES [167].
Recently, Izadiyan and co-authors developed an easy method for synthesizing magnetic core-shell Fe3O4/Au nanoparticles using Juglans regia green husk extract [168]. The investigation of the structure, magnetic and biological properties evidenced a high saturation magnetization, a plasmon resonance of gold at about 554 nm, a cytocompatible behavior of nanoparticles up to 500 μg/mL towards non-cancer cells and the nanoparticles’ ability to inhibit the proliferation of a colorectal cancer cell line (HT-29). The magneto-plasmonic nanoparticles obtained are therefore promising devices for cancer treatment, both as drug delivery systems and as tools for photothermal therapy.
Another green approach to synthesize magnetite-gold nanoparticles has concerned the use of Eucalyptus camaldulensis extract as a reducing agent of gold nanoparticles [169]. Composite nanostructures of about 6–20 nm in size were synthesized by reducing Au nanoparticles in situ on magnetite surface, by subjecting the magnetic nanoparticles together with chloroauric acid to an autoclave process. The nanostructures obtained showed the presence of organic compounds with a carboxyl group on nanostructures surface, which can be exploited for the separation and purification of biomolecules by magnetic field and drug delivery.
A different environmentally friendly approach to depositing gold (or silver) shell on a magnetite core has been developed by Dizaji et al. [170]. These authors used the Ligustrum vulgare extract as reducing and stabilizing agents to produce magneto-plasmonic nanoparticles using a facile, green, and reproducible route. The dimensions and the magnetic properties of the obtained nanoparticles can be modulated by varying the ratio between Au precursor (HAuCl4) and magnetic NPs, and the quantity of plant extract. Thus, the magneto and plasmonic nanoparticles obtained are potentially useful in the biomedical field for diagnosis and therapy.
The creation of a continuous metallic shell must be carefully controlled in order to not affect the surface plasmonic resonance properties (SPR). For instance, Chin and co-authors [171] developed magneto-plasmonic core-shell nanostructures using glucose; the nanoparticles obtained showed a range between 10 and 13 nm (shell thickness about 2–3 nm); they are superparamagnetic but presented insufficient SPR properties. In another study [172], a solution containing iron salts and glucose was mixed with a second solution containing sodium silicate (which can be synthesized by extraction from rice husk ash) and gold chloride. This simple one-pot−one-step process allowed the coprecipitation of iron salts, the reduction of gold chloride, and the formation of silica resulting in a unique nanocomposite of iron oxide, silica, and gold.
A green method for synthesizing Fe3O4/Au nanohybrid has been proposed also by Narayanan et al. [173], which used grape seed proanthocyanidin to both form magnetite NPs and reduce gold on their surface. The obtained nanohybrid showed a spherical morphology and size of about 35 nm, the magnetite core imparted superparamagnetic properties and the nanohybrid demonstrated good X-ray contrast. Moreover, the nanohybrids can be internalized by Mesenchymal Stem Cells (hMSCs) and were biocompatible up to 500 μg/mL, demonstrating once again that phytochemicals can be used to create hybrid nanoparticles for different applications in the biomedical field.
Finally, other authors proposed a facile and eco-friendly synthesis of Au–FexOy nanoclusters in an aqueous solution and at room temperature [174]. The FexOy nanoparticles were obtained by means of a co-precipitation process and coated with mPEG. The authors then used the amino acid L-histidine to promote the reduction of HAuCl4 onto colloidal Fe3O4. The nanoclusters obtained showed a size <100 nm, and useful magnetic properties which could be collected by a magnet. They were able to produce photoluminescence when excited at 488 nm and absorbed at NIR wavelengths.
Table 2 summarizes the green approaches adopted to synthesize magneto-plasmonic heterostructures.

5. Conclusions

This work provides an overview of the innovative green processes used to produce magnetic nanoparticles (in particular Fe3O4), Au nanoparticles and hybrid iron-oxide/Au nanostructures.
Different approaches have been developed to produce single magnetic or gold particles without resorting to using chemical reducing agents, potentially toxic to humans or the environment, while adopting plants and microorganisms, which are cost-effective and eco-friendly. These processes not only avoid the use of hazardous chemicals and toxic reducing and dispersing agents, but are often single-step, they are performed in aqueous environment, at room temperature, and they are scalable and economic from the industrial point of view.
Concerning the synthesis of magneto/plasmonic heterostructures, some green approaches have been already explored, obtaining good results in terms of structures and magneto-optical properties. However, new efforts are necessary to reach the same level of size, morphology and crystallinity control as the conventional synthesis method and to bring the processes investigated to an industrial scale. Moreover, current green procedures concern only a part of the entire synthesis process of hybrid nanostructures. Therefore, there is still a need for extra steps to obtain a complete eco-friendly production of magneto-plasmonic heterostructures. Nevertheless, the new technologies and knowledge developed will lead to the design of completely green processes in the coming years.

Author Contributions

Conceptualization, M.M.; writing—original draft preparation, M.M., C.M. and E.V.; supervision, M.M., C.M. and E.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kargozar, S.; Mozafari, M. Nanotechnology and Nanomedicine: Start small, think big. Mater. Today Proc. 2018, 5, 15492–15500. [Google Scholar] [CrossRef]
  2. Zhang, Y.; Li, M.; Gao, X.; Chen, Y.; Liu, T. Nanotechnology in cancer diagnosis: Progress, challenges and opportunities. J. Hematol. Oncol. 2019, 12, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Siddique, S.; Chow, J.C.L. Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials 2020, 10, 1700. [Google Scholar] [CrossRef] [PubMed]
  4. Setua, S.; Jaggi, M.; Yallapu, M.M.; Chauhan, S.C.; Danilushkina, A.; Lee, H.; Choi, I.S.; Fakhrullin, R.; Degli Esposti, L.; Tampieri, A.; et al. Targeted and theranostic applications for nanotechnologies in medicine. In Micro and Nano Technologies, Nanotechnologies in Preventive and Regenerative Medicine; Uskoković, V., Dragan, P.U., Eds.; Elsevier: Amsterdam, The Netherlands, 2018; Chapter 6; pp. 399–511. ISBN 9780323480635. [Google Scholar] [CrossRef]
  5. Khan, I.; Saeed, K.; Khan, I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019, 12, 908–931. [Google Scholar] [CrossRef]
  6. Chen, F.; Ehlerding, E.B.; Cai, W. Theranostic nanoparticles. J. Nucl. Med. 2014, 55, 1919–1922. [Google Scholar] [CrossRef] [Green Version]
  7. Revia, R.A.; Zhang, M. Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: Recent advances. Mater. Today 2016, 19, 157–168. [Google Scholar] [CrossRef]
  8. Mukherjee, S.; Liang, L.; Veiseh, O. Recent advancements of magnetic nanomaterials in cancer therapy. Pharmaceutics 2020, 12, 147. [Google Scholar] [CrossRef] [Green Version]
  9. Fathi Karkan, S.; Mohammadhosseini, M.; Panahi, Y.; Milani, M.; Zarghami, N.; Akbarzadeh, A.; Abasi, E.; Hosseini, A.; Davaran, S. Magnetic nanoparticles in cancer diagnosis and treatment: A review. Artif. Cells Nanomed. Biotechnol. 2017, 45, 1–5. [Google Scholar] [CrossRef]
  10. Miola, M.; Ferraris, S.; Pirani, F.; Multari, C.; Bertone, E.; Žužek Rožman, K.; Kostevšek, N.; Verné, E. Reductant-free synthesis of magnetoplasmonic iron oxide-gold Nanoparticles. Ceram. Int. 2017, 43, 15258–15265. [Google Scholar] [CrossRef]
  11. Multari, C.; Miola, M.; Laviano, F.; Gerbaldo, R.; Pezzotti, G.; Debellis, D.; Verné, E. Magnetoplasmonic nanoparticles for photothermal therapy. Nanotechnology 2019, 30, 255705. [Google Scholar] [CrossRef]
  12. Gao, Q.; Zhang, J.; Gao, J.; Zhang, Z.; Zhu, H.; Wang, D. Gold Nanoparticles in Cancer Theranostics. Front. Bioeng. Biotechnol. 2021, 9, 647905. [Google Scholar] [CrossRef]
  13. Curry, T.; Kopelman, R.; Shilo, M.; Popovtzer, R. Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermaltherapy. Contrast Media Mol. Imaging 2014, 9, 53–61. [Google Scholar] [CrossRef]
  14. Nguyen, T.; Mammeri, F.; Ammar, S. Iron Oxide and Gold Based Magneto-Plasmonic Nanostructures for Medical Applications: A Review. Nanomaterials 2018, 8, 149. [Google Scholar] [CrossRef] [Green Version]
  15. Tarkistani, M.A.M.; Komalla, V.; Kayser, V. Recent Advances in the Use of Iron–Gold Hybrid Nanoparticles for Biomedical Applications. Nanomaterials 2021, 11, 1227. [Google Scholar] [CrossRef]
  16. Tri, P.N.; Ouellet-Plamondon, C.; Rtimi, S.; Assadi, A.A.; Nguyen, T.A. Methods for Synthesis of Hybrid Nanoparticles. In Micro and Nano Technologies, Noble Metal-Metal Oxide Hybrid Nanoparticles; Mohapatra, S., Nguyen, T.A., Nguyen-Tri, P., Eds.; Woodhead Publishing: Sawston, UK, 2019; Chapter 3; pp. 51–63. ISBN 9780128141342. [Google Scholar] [CrossRef]
  17. Xu, C.; Ho, D.; Xie, J.; Wang, C.; Kohler, N.; Walsh, E.G.; Morgan, J.R.; Chin, Y.E.; Sun, S. Au–Fe3O4 dumbbell nanoparticles as dual-functional probes. Angew. Chem. Int. Ed. 2008, 47, 173–176. [Google Scholar] [CrossRef]
  18. Choi, S.H.; Na, H.B.; Park, Y.I.; An, K.; Kwon, S.G.; Jang, Y.; Park, M.H.; Moon, J.; Son, J.S.; Song, I.C.; et al. Simple and generalized synthesis of oxide-metal heterostructured nanoparticles and their applications. J. Am. Chem. Soc. 2008, 130, 15573–15580. [Google Scholar] [CrossRef]
  19. Otari, S.V.; Kalia, V.C.; Bisht, A.; Kim, I.W.; Lee, J.K. Green Synthesis of Silver-Decorated Magnetic Particles for Efficient and Reusable Antimicrobial Activity. Materials 2021, 14, 7893. [Google Scholar] [CrossRef]
  20. Woodard, L.E.; Dennis, C.L.; Borchers, J.A.; Anilchandra Attaluri Velarde, E.; Dawidczyk, C.; Searson, P.C.; Pomper, M.G.; Ivkov, R. Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality. Sci. Rep. 2018, 8, 12706. [Google Scholar] [CrossRef]
  21. Gul, S.; Khan, S.B.; Rehman, I.U.; Khan, M.A.; Khan, M.I. A Comprehensive Review of Magnetic Nanomaterials Modern Day Theranostics. Front. Mater. 2019, 6, 179. [Google Scholar] [CrossRef] [Green Version]
  22. Kolhatkar, A.G.; Jamison, A.C.; Litvinov, D.; Willson, R.C.; Randall Lee, T. Tuning the Magnetic Properties of Nanoparticles. Int. J. Mol. Sci. 2013, 14, 15977–16009. [Google Scholar] [CrossRef] [Green Version]
  23. Tancredi, P.; da Costa, L.S.; Calderon, S.; Moscoso-Londoño, O.; Socolovsky, L.M.; Ferreira, P.J.; Muraca, D.; Zanchet, D.; Knobel, M. Exploring the synthesis conditions to control the morphology of gold-iron oxide heterostructures. Nano Res. 2019, 12, 1781–1788. [Google Scholar] [CrossRef]
  24. Hadilou, N.; Souri, S.; Navid, H.A.; Bonabi, R.S.; Anvari, A.; Palpant, B. An optimal architecture of magneto-plasmonic core–shell nanoparticles for potential photothermal applications. Phys. Chem. Chem. Phys. 2020, 22, 14318. [Google Scholar] [CrossRef] [PubMed]
  25. Dumur, F.; Dumas, E.; Mayer, C.R. Functionalization of Gold Nanoparticles by Inorganic Entities. Nanomaterials 2020, 10, 548. [Google Scholar] [CrossRef] [Green Version]
  26. Mazloomi-Rezvani, M.; Salami-Kalajahi, M.; Roghani-Mamaqani, H.; Pirayesh, A. Effect of surface modification with various thiol compounds on colloidal stability of gold nanoparticles. Appl. Organomet. Chem. 2018, 32, e4079. [Google Scholar] [CrossRef]
  27. Chen, H.; Hu, H.; Tao, C.; Clauson, R.M.; Moncion, I.; Luan, X.; Hwang, S.; Sough, A. Self-Assembled Au@Fe Core/Satellite Magnetic Nanoparticles for Versatile Biomolecule Functionalization. ACS Appl. Mater. Interfaces 2019, 11, 23858–23869. [Google Scholar] [CrossRef]
  28. Liang, C.H.; Wang, C.V.; Lin, Y.C.; Chen, C.H.; Wong, C.H.; Wu, C.Y. Iron Oxide/Gold Core/Shell Nanoparticles for Ultrasensitive Detection of Carbohydrate−Protein Interactions. Anal. Chem. 2009, 81, 7750–7756. [Google Scholar] [CrossRef] [PubMed]
  29. Sood, A.; Arora, V.; Shah, J.; Kotnala, R.K.; Jain, T.K. Multifunctional gold coated iron oxide core-shell nanoparticles stabilized using thiolated sodium alginate for biomedical applications. Mat. Sci. Eng. C 2017, 80, 274–281. [Google Scholar] [CrossRef]
  30. Brennan, G.; Bergamino, S.; Pescio, M.; Tofail, S.A.M.; Silien, C. The Effects of a Varied Gold Shell Thickness on Iron Oxide Nanoparticle Cores in Magnetic ManipulationT1 and T2 MRI Contrasting, and Magnetic Hyperthermia. Nanomaterials 2020, 10, 2424. [Google Scholar] [CrossRef]
  31. Meen, T.H.; Tsai, J.K.; Chao, S.M.; Lin, Y.C.; Wu, T.C.; Chang, T.Y.; Ji, L.W.; Water, W.; Chen, W.R.; Tang, I.T.; et al. Surface plasma resonant effect of gold nanoparticles on the photoelectrodes of dye-sensitized solar cells. Nanoscale Res. Lett. 2013, 8, 450. [Google Scholar] [CrossRef] [Green Version]
  32. Abdulla-Al-Mamun, M.; Kusumoto, Y.; Zannat, T.; Horie, Y.; Manaka, H. Au-ultrathin functionalized core–shell (Fe3O4@Au) monodispersed nanocubes for a combination of magnetic/plasmonic photothermal cancer cell killing. RSC Adv. 2013, 3, 7816–7827. [Google Scholar] [CrossRef]
  33. Wang, H.; Brandl, D.W.; Le, F.; Nordlander, P.; Halas, N.J. Nanorice: A hybrid plasmonic nanostructure. Nano Lett. 2006, 6, 827–832. [Google Scholar] [CrossRef]
  34. Huang, C.; Jiang, J.; Muangphat, C.; Sun, X.; Hao, Y. Trapping Iron Oxide into Hollow Gold Nanoparticles. Nanoscale Res. Lett. 2011, 6, 43. [Google Scholar] [CrossRef] [Green Version]
  35. Shevchenko EVBodnarchuk, M.Y.; Kovalenko, M.V.; Talapin, D.V.; Smith, R.K.; Aloni, S.; Heiss, W.; Alivisatos, A.P. Gold/Iron Oxide Core/Hollow-Shell Nanoparticles. Adv. Mater. 2008, 20, 4323–4329. [Google Scholar] [CrossRef]
  36. Vines, J.B.; Yoon, J.H.; Ryu, N.E.; Lim, D.J.; Park, H. Gold Nanoparticles for Photothermal Cancer Therapy. Front Chem. 2019, 7, 167. [Google Scholar] [CrossRef] [Green Version]
  37. Shams, S.F.; Ghazanfari, M.R.; Schmitz-Antoniak, C. Magnetic-Plasmonic Heterodimer Nanoparticles: Designing Contemporarily Features for Emerging Biomedical Diagnosis and Treatments. Nanomaterials 2019, 9, 97. [Google Scholar] [CrossRef] [Green Version]
  38. Kang, M.S.; Lee, S.Y.; Kim, K.S.; Han, D.W. State of the Art Biocompatible Gold Nanoparticles for Cancer Theragnosis. Pharmaceutics 2020, 12, 701. [Google Scholar] [CrossRef] [PubMed]
  39. Tam, S.Y.; Tam, V.C.W.; Ramkumar, S.; Khaw, M.L.; Law, H.K.W.; Lee, S.W.Y. Review on the Cellular Mechanisms of Low-Level Laser Therapy Use in Oncology. Front. Oncol. 2020, 10, 1255. [Google Scholar] [CrossRef]
  40. Zhou, S.; Li, D.; Lee, C.; Xie, J. Nanoparticle Phototherapy in the Era of Cancer Immunotherapy. Trends Chem. 2020, 2, 1082–1095. [Google Scholar] [CrossRef]
  41. Yu, Y.; Yang, T.; Sun, T. New insights into the synthesis, toxicity and applications of gold nanoparticles in CT imaging and treatment of cancer. Nanomedicine 2020, 15, 1127–1145. [Google Scholar] [CrossRef]
  42. Mukha, I.; Chepurna, O.; Vityuk, N.; Khodko, A.; Storozhuk, L.; Dzhagan, V.; Zahn, D.R.T.; Ntziachristos, V.; Chmyrov, A.; Ohulchanskyy, T.Y. Multifunctional Magneto-Plasmonic Fe3O4/Au Nanocomposites: Approaching Magnetophoretically-Enhanced Photothermal Therapy. Nanomaterials 2021, 11, 1113. [Google Scholar] [CrossRef]
  43. Muniz-Miranda, M.; Muniz-Miranda, F.; Giorgetti, E. Spectroscopic and Microscopic Analyses of Fe3O4/Au Nanoparticles Obtained by Laser Ablation in Water. Nanomaterials 2020, 10, 132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Reguera, J.; Jiménez de Aberasturi, D.; Winckelmans, N.; Langer, J.; Bals, S.; Liz-Marzán, L.M. Synthesis of Janus plasmonic–magnetic, star–sphere nanoparticles, and their application in SERS detection. Faraday Discuss. 2016, 191, 47–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Wheeler, D.A.; Adams, S.A.; López-Luke, T.; Torres-Castro, A.; Zhang, J.Z. Magnetic Fe3O4-Au core-shell nanostructures for surface enhanced Raman scattering. Ann. Phys. 2012, 524, 670–679. [Google Scholar] [CrossRef]
  46. Arias, L.S.; Pessan, J.P.; Vieira, A.P.M.; Lima, T.M.T.; Delbem, A.C.B.; Monteiro, D.R. Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity. Antibiotics 2018, 7, 46. [Google Scholar] [CrossRef] [Green Version]
  47. Montiel Schneider, M.G.; Martín, M.J.; Otarola, J.; Vakarelska, E.; Simeonov, V.; Lassalle, V.; Nedyalkova, M. Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives. Pharmaceutics 2022, 14, 204. [Google Scholar] [CrossRef]
  48. Liu, X.; Zhang, Y.; Wang, Y.; Zhu, W.; Li, G.; Ma, X.; Zhang, Y.; Chen, S.; Tiwari, S.; Shi, K.; et al. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy. Theranostics 2020, 10, 3793–3815. [Google Scholar] [CrossRef]
  49. Peiravi, M.; Eslami, H.; Ansari, M.; Zare-Zardini, H. Magnetic hyperthermia: Potentials and limitations. J. Indian Chem. Soc. 2022, 99, 100269. [Google Scholar] [CrossRef]
  50. Roti, J.L. Cellular responses to hyperthermia (40–46 °C): Cell killing and molecular events. Int. J. Hyperth. 2008, 24, 3–15. [Google Scholar] [CrossRef]
  51. Spirou, S.V.; Basini, M.; Lascialfari, A.; Sangregorio, C.; Innocenti, C. Magnetic Hyperthermia and Radiation Therapy: Radiobiological Principles and Current Practice. Nanomaterials 2018, 8, 401. [Google Scholar] [CrossRef] [Green Version]
  52. Wust, P.; Hildebrandt, B.; Sreenivasa, G.; Rau, B.; Gellermann, J.; Riess, H.; Felix, R.; Schlag, P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002, 3, 487–497. [Google Scholar] [CrossRef]
  53. Horsman, M.R.; Overgaard, J. Hyperthermia: A potent enhancer of radiotherapy. Clin. Oncol. 2007, 17, 418–426. [Google Scholar] [CrossRef] [PubMed]
  54. Overgaard, J. The heat is (still) on—The past and future of hyperthermic radiation oncology. Radiother. Oncol. 2013, 109, 185–187. [Google Scholar] [CrossRef] [PubMed]
  55. Kok, H.P.; Crezee, J.; Franken, N.A.P.; Stalpers, L.J.A.; Barendsen, G.W.; Bel, A. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions. Int. J. Radiat. Oncol. Biol. Phys. 2014, 88, 739–745. [Google Scholar] [CrossRef]
  56. Vaupel, P.W.; Kelleher, D.K. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int. J. Hyperth. 2010, 26, 211–223. [Google Scholar] [CrossRef]
  57. Coss, R.A.; Dewey, W.C.; Bamburg, J.R. Effects of hyperthermia on dividing Chinese hamster ovary cells and on microtubules in vitro. Cancer Res. 1982, 42, 1059. [Google Scholar]
  58. Datta, N.R.; Puric, E.; Klingbiel, D.; Gomez, S.; Bodis, S. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: A systematic review and meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 2016, 94, 1073–1087. [Google Scholar] [CrossRef]
  59. Datta, N.R.; Rogers, S.; Ordóñez, S.G.; Puric, E.; Bodis, S. Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis. Int. J. Hyperth. 2016, 32, 31–40. [Google Scholar] [CrossRef]
  60. Deatsch, A.E.; Evans, B.A. Heating efficiency in magnetic nanoparticle hyperthermia. J. Magn. Magn. Mater. 2014, 354, 163–172. [Google Scholar] [CrossRef]
  61. Storozhuk, L.; Besenhard, M.O.; Mourdikoudis, S.; LaGrow, A.P.; Lees, M.R.; Tung LDGavriilidis, A.; Kim Thanh, N.T. Stable Iron Oxide Nanoflowers with Exceptional Magnetic Heating Efficiency: Simple and Fast Polyol Synthesis. ACS Appl. Mater. Interfaces 2021, 13, 45870–45880. [Google Scholar] [CrossRef]
  62. Gupta, R.; Sharma, D. Therapeutic response differences between 2D and 3D tumor models of magnetic hyperthermia. Nanoscale Adv. 2021, 3, 3663–3680. [Google Scholar] [CrossRef]
  63. Kumar, C.S.S.R.; Mohammad, F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev. 2011, 63, 789–808. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Urries, I.; Munoz, C.; Gomez, L.; Marquina, C.; Sebastian, V.; Arrueboad, M.; Santamaria, J. Magneto-plasmonic nanoparticles as theranostic platforms for magnetic resonance imaging, drug delivery and NIR hyperthermia applications. Nanoscale 2014, 6, 9230–9240. [Google Scholar] [CrossRef] [Green Version]
  65. Popescu, R.C.; Andronescu, E.; Vasile, B.S. Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine. Nanomaterials 2019, 9, 1791. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Amina, S.J.; Guo, B. A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle. Int. J. Nanomed. 2020, 15, 9823–9857. [Google Scholar] [CrossRef]
  67. Billings, C.; Langley, M.; Warrington, G.; Mashali, F.; Johnson, J.A. Magnetic Particle Imaging: Current and Future Applications, Magnetic Nanoparticle Synthesis Methods and Safety Measures. Int. J. Mol. Sci. 2021, 22, 7651. [Google Scholar] [CrossRef]
  68. Moradi Khaniabadi, P.; Shahbazi-Gahrouei, D.; Jaafar, M.S.; Majid, A.M.S.A.; Moradi Khaniabadi, B.; Shahba-zi-Gahrouei, S. Magnetic Iron Oxide Nanoparticles as T2 MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell. Avicenna J. Med. Biotechnol. 2017, 9, 181–188. [Google Scholar]
  69. Ahmad, T.; Bae, H.; Rhee, I.; Chang, Y.; Jin, S.U.; Hong, S. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging. J. Nanosci. Nanotechnol. 2012, 12, 5132–5137. [Google Scholar] [CrossRef] [Green Version]
  70. Besenhard, M.O.; Panariello, L.; Kiefer, C.; LaGrow, A.P.; Storozhuk, L.; Perton, F.; Begin, S.; Mertz, D.; Thanh, N.T.K.; Gavriilidis, A. Small iron oxide nanoparticles as MRI T1 contrast agent: Scalable inexpensive water-based synthesis using a flow reactor. Nanoscale 2021, 13, 8795–8805. [Google Scholar] [CrossRef]
  71. Jeon, M.; Halbert, M.V.; Stephen, Z.R.; Zhang, M. Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospecti-ves. Adv. Mater. 2021, 33, e1906539. [Google Scholar] [CrossRef]
  72. Yang, X.; Guoqing, S.; Zang, Y.; Wang, W.; Qui, Y.; Han, S.; Li, H. Applications of Magnetic Particle Imaging in Biomedicine: Advancements and Prospects. Front. Physiol. 2022, 13, 898426. [Google Scholar] [CrossRef]
  73. Israel, L.L.; Galstyan, A.; Holler, E.; Ljubimova, J.Y. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J. Control. Release 2020, 320, 45–62. [Google Scholar] [CrossRef] [PubMed]
  74. Dong, Y.C.; Hajfathalian, M.; Maidment, P.S.N.; Hsu, J.C.; Naha, P.C.; Si-Mohamed, S.; Breuilly, M.; Kim, J.; Chhour, P.; Douek, P.; et al. Effect of Gold Nanoparticle Size on Their Properties as Contrast Agents for Computed Tomography. Sci. Rep. 2019, 9, 14912. [Google Scholar] [CrossRef] [Green Version]
  75. Qin, M.; Wang, C.; Zhu, J.; Yong, L.; Wang, H.; Yang, L. Synthesis of Differently Sized Gold Nanoparticles for SERS Applications in the Detection of Mala-chite Green. Spectroscopy 2021, 36, 41–46. [Google Scholar]
  76. Tian, F.; Bonnier, F.; Casey, A.; Shanahana, A.E.; Byrne, H.J. Surface enhanced Raman scattering with gold nanoparticles: Effect of particle shape. Anal. Methods 2014, 6, 9116–9123. [Google Scholar] [CrossRef] [Green Version]
  77. Hong, S.; Li, X. Optimal Size of Gold Nanoparticles for Surface-Enhanced Raman Spectroscopy under Different Conditions. J. Nanomater. 2013, 2013, 790323. [Google Scholar] [CrossRef]
  78. Mikoliunaite, L.; Talaikis, M.; Michalowska, A.; Dobilas, J.; Stankevic, V.; Kudelski, A.; Niau, G. Thermally Stable Magneto-Plasmonic Nanoparticles for SERS with Tunable Plasmon Resonance. Nanomaterials 2022, 12, 2860. [Google Scholar] [CrossRef]
  79. Zhou, X.; Xu, W.; Wang, Y.; Kuang, Q.; Shi, Y.; Zhong, L.; Zhang, Q. Fabrication of cluster/shell Fe3O4/au nanoparticles and application in protein detection via a sers method. J. Phys. Chem. C 2010, 114, 19607–19613. [Google Scholar] [CrossRef]
  80. Yang, T.; Guo, X.; Wang, H.; Fu, S.; Wen, Y.; Yang, H. Magnetically optimized SERS assay for rapid detection of trace drug-related biomarkers in saliva and fingerprints. Biosens. Bioelectron. 2015, 68, 350–357. [Google Scholar] [CrossRef] [PubMed]
  81. Pang, Y.; Wang, C.; Wang, J.; Sun, Z.; Xiao, R.; Wang, S. Fe3O4@Ag magnetic nanoparticles for microRNA capture and duplex-specific nuclease signal amplification based SERS detection in cancer cells. Biosens. Bioelectron. 2016, 79, 574–580. [Google Scholar] [CrossRef]
  82. Tang, C.; He, Z.; Liu, H.; Liu, H.; Xu, Y.; Huang, H.; Yang, G.; Xiao, Z.; Li, S.; Liu, H.; et al. Application of magnetic nanoparticles in nucleic acid detection. J. Nanobiotechnol. 2020, 18, 62. [Google Scholar] [CrossRef] [Green Version]
  83. Szunerits, S.; Saada TNMeziane, D.; Boukherroub, R. Magneto-Optical Nanostructures for Viral Sensing. Nanomaterials 2020, 10, 1271. [Google Scholar] [CrossRef]
  84. Zhang, L.; Xu, J.; Mi, L.; Gong, H.; Jiang, S.; Yu, Q. Multifunctional magnetic–plasmonic nanoparticles for fast concentration and sensitive detection of bacteria using SERS. Biosens. Bioelectron. 2012, 31, 130–136. [Google Scholar] [CrossRef]
  85. Wang, C.; Wang, J.; Li, M.; Qu, X.; Zhang, K.; Rong, Z.; Xiao, R.; Wang, S. A rapid sers method for label-free bacteria detection using polyethylenimine-modified au-coated magnetic microspheres and nanoparticles. Analyst 2016, 141, 6226–6238. [Google Scholar] [CrossRef]
  86. Zhang, X.; Zhang, X.; Luo, C.; Liu, Z.; Chen, Y.; Dong, S.; Jiang, C.; Yang, S.; Wang, F.; Xiao, X. Enhanced Raman Scattering Detection of Viruses. Small 2019, 15, e1805516. [Google Scholar] [CrossRef]
  87. Temelie, M.; Popescu, R.C.; Cocioaba, D.; Vasile, B.S.; Savu, D. Biocompatibility study of magnetite nanoparticle synthesized using a Green method. Rom. J. Phys. 2018, 63, 1–13. [Google Scholar]
  88. Annu, S.A.; Ikram, S.; Yudha, S. Biosynthesis of gold nanoparticles: A green approach. J. Photochem. Photobiol. B Biol. 2016, 161, 141–153. [Google Scholar] [CrossRef]
  89. Stafford, S.; Serrano Garcia, R.; Gun’ko, Y.K. Multimodal Magnetic-Plasmonic Nanoparticles for Biomedical Applications. Appl. Sci. 2018, 8, 97; [Google Scholar] [CrossRef] [Green Version]
  90. Anik, M.I.; Khalid Hossain, M.; Hossain, I.; Mahfuz, A.M.U.B.; Tayebur Rahman, M.; Ahmed, I. Recent progress of magnetic nanoparticles in biomedical applications: A review. Nano Sel. 2021, 2, 1146–1186. [Google Scholar] [CrossRef]
  91. Singh, P.; Kim, Y.J.; Zhang, D.; Yang, D.C. Biological Synthesis of Nanoparticles from Plants and Microorganisms. Trends Biotechnol. 2016, 34, 588–599. [Google Scholar] [CrossRef]
  92. Fariq, A.; Khan, T.; Yasmin, A. Microbial synthesis of nanoparticles and their potential applications in biomedicine. J. Appl. Biomed. 2017, 15, 241–248. [Google Scholar] [CrossRef]
  93. Thakkar, K.N.; Mhatre, S.S.; Parikh, R.Y. Biological synthesis of metallic nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2010, 6, 257–262. [Google Scholar] [CrossRef] [PubMed]
  94. Dahl, J.A.; Maddux, B.L.S.; Hutchison, J.E. Toward greener nanosynthesis. Chem. Rev. 2007, 107, 2228–2269. [Google Scholar] [CrossRef] [PubMed]
  95. Chopra, H.; Bibi, S.; Singh, I.; Hasan, M.M.; Khan, M.S.; Yousafi, Q.; Baig, A.A.; Rahman, M.M.; Islam, F.; Emran, T.B.; et al. Green Metallic Nanoparticles: Biosynthesis to Applications. Front. Bioeng. Biotechnol. 2022, 10, 874742. [Google Scholar] [CrossRef] [PubMed]
  96. Darroudi, M.; Ahmad, M.B.; Zamiri, R.; Zak, A.K. Time-dependent effect in green synthesis of silver nanoparticles. Int. J. Nanomed. 2011, 6, 677–681. [Google Scholar] [CrossRef] [Green Version]
  97. Busi, S.; Rajkumari, J. Microbially synthesized nanoparticles as next generation antimicrobials: Scope and applications. In Nanoparticles in Pharmacotherapy; William Andrew Publishing: Norwich, NY, USA, 2019; pp. 485–524. [Google Scholar] [CrossRef]
  98. Majeed, S.; Danish, M.; Ibrahim, M.N.M.; Sekeri, S.H.; Ansari, M.T.; Nanda, A.; Ahmad, G. Bacteria Mediated Synthesis of Iron Oxide Nanoparticles and Their Antibacterial, Antioxidant, Cytocompatibility Properties. J. Clust. Sci. 2021, 32, 1083–1094. [Google Scholar] [CrossRef]
  99. Honary, S.; Fathabad, E.G.; Paji, Z.K.; Eslamifar, M. A novel biological synthesis of gold nanoparticle by enterobacteriaceae family Trop. J. Pharm. Res. 2012, 11, 887–891. [Google Scholar]
  100. Khan, A.A.; Khan, S.; Khan, S.; Rentschler, S.; Laufer, S.; Deigner, H.-P. Biosynthesis of iron oxide magnetic nanoparticles using clinically isolated Pseudomonas aeruginosa. Sci. Rep. 2021, 11, 20503. [Google Scholar] [CrossRef]
  101. Mandal, D.; Bolander, M.E.; Mukhopadhyay, D.; Sarkar, G.; Mukherjee, P. The use of microorganisms for the formation of metal nanoparticles and their application. Appl. Microbiol. Biotechnol. 2006, 69, 485–492. [Google Scholar] [CrossRef]
  102. Rautaray, D.; Bansal, V.; Ahmad, A.; Sarkar, I.; Mohammad Yusuf, S.; Sanyal, M.; Sastry, M. Extracellular Biosynthesis of Magnetite using FungiAtul Bharde. Small 2006, 2, 135–141. [Google Scholar] [CrossRef]
  103. Abdeen, M.; Sabry, S.; Ghozlan, H.; El-Gendy, A.A.; Carpenterh, E.E. Microbial-Physical Synthesis of Fe and Fe3O4 Magnetic Nanoparticles Using Aspergillus niger YESM1 and Supercritical Condition of Ethanol. J. Nanomater. 2016, 2016, 9174891. [Google Scholar] [CrossRef] [Green Version]
  104. Bing, W.; Sun, H.; Wang, F.; Song, Y.; Ren, J. Hydrogen-producing hyperthermophilic bacteria synthesized size-controllable fine gold nanoparticles with excellence for eradicating biofilm and antibacterial applications. J. Mater. Chem. B 2018, 6, 4602–4609. [Google Scholar] [CrossRef]
  105. Ahmed, E.; Kalathil, S.; Shi, L.; Alharbi, O.; Wang, P. Synthesis of ultra-small platinum, palladium and gold nanoparticles by Shewanella loihica PV-4 electrochemically active biofilms and their enhanced catalytic activities. J. Saudi Chem. Soc. 2018, 22, 919–929. [Google Scholar] [CrossRef]
  106. Jafari, M.; Rokhbakhsh-Zamin, F.; Shakibaie, M.; Moshafi, M.H.; Ameri, A.; Rahimi, A.R.; Forootanfar, H. Cytotoxic and antibacterial activities of biologically synthesized gold nanoparticles assisted by Micrococcus yunnanensis strain J2. Biocatal. Agric. Biotechnol. 2018, 15, 245–253. [Google Scholar] [CrossRef]
  107. Nangia, Y.; Wangoo, N.; Goyal, N.; Shekhawat, G.; Suri, C.R. A novel bacterial isolate Stenotrophomonas maltophilia as living factory for synthesis of gold nanoparticles. Microb. Cell Factories 2009, 8, 39–46. [Google Scholar] [CrossRef] [Green Version]
  108. Bharde, A.; Kulkarni, A.; Rao, M.; Prabhune, A.; Sastry, M. Bacterial enzyme mediated biosynthesis of gold nanoparticles. J. Nanosci. Nanotechnol. 2007, 7, 4369–4377. [Google Scholar] [CrossRef]
  109. He, S.; Guo, Z.; Zhang, Y.; Zhang, S.; Wang, J.; Gu, N. Biosynthesis of gold nanoparticles using the bacteria Rhodopseudomonas capsulata. Mater. Lett. 2007, 61, 3984–3987. [Google Scholar] [CrossRef]
  110. Baker, S.; Nagendra, M.N.; Satish Prasad, S. Endogenic mediated synthesis of gold nanoparticles bearing bactericidal activity. J. Microsc. Ultrastruct. 2016, 4, 162–166. [Google Scholar] [CrossRef] [Green Version]
  111. Husseiny, M.I.; El-Aziz, M.A.; Badr, Y.; Mahmoud, M.A. Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2007, 67, 1003–1006. [Google Scholar] [CrossRef]
  112. Pourali, P.; Badiee, S.H.; Manafi, S.; Noorani, T.; Rezaei, A.; Yahyaei, B. Biosynthesis of gold nanoparticles by two bacterial and fungal strains, Bacillus cereus and Fusarium oxysporum, and assessment and comparison of their nanotoxicity in vitro by direct and indirect assays. Electron. J. Biotechnol. 2017, 29, 86–93. [Google Scholar] [CrossRef]
  113. Gopal, J.V.; Gopal, J.V.; Thenmozhi, M.; Kannabiran, K.; Rajakumar, G.; Velayutham, K.; Rahuman, A.A. Actinobacteria mediated synthesis of gold nanoparticles using Streptomyces sp. VITDDK3 and its antifungal activity. Mater. Lett. 2013, 93, 360–362. [Google Scholar] [CrossRef]
  114. Sarkar, J.; Ray, S.; Chattopadhyay, D.; Laskar, A.; Acharya, K. Mycogenesis of gold nanoparticles using a phytopathogen Alternaria alternata. Bioprocess Biosyst. Eng. 2012, 35, 637–643. [Google Scholar] [CrossRef]
  115. Husen, A.; Siddiqi, K.S. Plants and microbes assisted selenium nanoparticles: Characterization and application. J. Nanobiotechnol. 2014, 12, 28–39. [Google Scholar] [CrossRef] [PubMed]
  116. Maliszewska, I. Microbial mediated synthesis of gold nanoparticles: Preparation, characterization and cytotoxicity studies. Dig. J. Nanomater. Biostructures 2013, 8, 1123–1131. [Google Scholar]
  117. Mishra, A.N.; Bhadauria, S.; Gaur, M.S.; Pasricha, R. Extracellular microbial synthesis of gold nanoparticles using fungus Hormoconis Resinae. JOM 2010, 62, 45–48. [Google Scholar] [CrossRef]
  118. Sanghi, R.; Verma, P.; Puri, S. Enzymatic formation of gold nanoparticles using Phanerochaete chrysosporium. Adv. Chem. Eng. Sci. 2011, 1, 154–162. [Google Scholar] [CrossRef] [Green Version]
  119. Castro, M.E.; Cottet, L.; Castillo, A. Biosynthesis of gold nanoparticles by extracellular molecules produced by the phytopathogenic fungus Botrytis cinereal. Mater. Lett. 2014, 115, 42–44. [Google Scholar] [CrossRef]
  120. Suganya, K.S.U.; Govindaraju, K.; Kumar, G.ù.; Manickan, E. Blue green alga mediated synthesis of gold nanoparticles and its antibacterial efficacy against Gram positive organisms. Mater. Sci. Eng. C Mater. Biol. Appl. C. 2015, 47, 351–356. [Google Scholar] [CrossRef]
  121. Costa, L.H.; Hemmer, J.; Wanderlind, E.H.; Gerlach, O.M.S.; Santos, A.L.H.; Tamanaha, M.S.; Bella-Cruz, A.; Corrêa, R.; Bazani, H.A.G.; Radetski, C.M.; et al. Green Synthesis of Gold Nanoparticles Obtained from Algae Sargassum cymosum: Optimization, Characterization and Stability. BioNanoScience 2020, 10, 1049–1062. [Google Scholar] [CrossRef]
  122. Revati, A.K.; Pandey, B.D. Microbial synthesis of iron-based nanomaterials—A review. Bull. Mater. Sci. 2011, 34, 191–198. [Google Scholar]
  123. Lower, B.H.; Bazylinski, D.A. The bacterial magnetosome: A unique prokaryotic organelle. J. Mol. Microbiol. Biotechnol. 2013, 23, 63–80. [Google Scholar] [CrossRef]
  124. Das, S.K.; Marsili, E. Bioinspired Metal Nanoparticle: Synthesis, Properties and Application. In Nanomaterials; Rahman, M.M., Ed.; IntechOpen: London, UK, 2011; Available online: https://www.intechopen.com/chapters/25349 (accessed on 1 June 2022). [CrossRef] [Green Version]
  125. Samanta SAgarwal SNair, K.K.; Harris, R.A.; Swart, H. Biomolecular assisted synthesis and mechanism of silver and gold nanoparticles. Mater. Res. Express 2019, 6, 082009. [Google Scholar] [CrossRef]
  126. Al-khattaf, F.S. Gold and silver nanoparticles: Green synthesis, microbes, mechanism, factors, plant disease management and environmental risks. Saudi J. Biol. Sci. 2021, 28, 3624–3631. [Google Scholar] [CrossRef]
  127. Menon, S.; Rajeshkumar, S.; Venkat Kumar, S. A review on biogenic synthesis of gold nanoparticles, characterization, and its applications. Resour. Effic. Technol. 2017, 3, 516–527. [Google Scholar] [CrossRef]
  128. Kumar, D.A.; Palanichamy, V.; Roopan, S.M. Green synthesis of silver nanoparticles using Alternanthera dentata leaf extract at room temperature and their antimicrobial activity. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 127, 168–171. [Google Scholar] [CrossRef]
  129. Mishra, A.; Tripathy, S.K.; Yun, S.I. Fungus mediated synthesis of gold nanoparticles and their conjugation with genomic DNA isolated from Escherichia coli and Staphylococcus aureus. Process Biochem. 2012, 47, 701–711. [Google Scholar] [CrossRef]
  130. Singh, J.; Dutta, T.; Kim, K.-H.; Rawat, M.; Samddar, P.; Kumar, P. ‘Green’ synthesis of metals and their oxide nanoparticles: Applications for environmental remediation. J. Nanobiotechnol. 2018, 16, 84. [Google Scholar] [CrossRef]
  131. Sidhu, A.K. Green Synthesis: An Eco-friendly Route for the Synthesis of Iron Oxide Nanoparticles. Front. Nanotechnol. 2021, 3, 655062. [Google Scholar] [CrossRef]
  132. Kuppusamy, P.; Yusoff, M.M.; Maniam, G.P.; Govindan, N. Biosynthesis of metallic nanoparticles using plant derivatives and their new avenues in pharmacological applications—An updated report. Saudi Pharm. J. 2016, 24, 473–484. [Google Scholar] [CrossRef]
  133. Can, M. Green gold nanoparticles from plant-derived materials: An overview of the reaction synthesis types, conditions, and applications. Rev. Chem. Eng. 2020, 7, 859–877. [Google Scholar] [CrossRef]
  134. Shreyash, N.; Bajpai, S.; Khan, M.A.; Vijay, Y.; Tiwary, S.K.; Sonker, M. Green Synthesis of Nanoparticles and Their Biomedical Applications: A Review. ACS Appl. Nano Mater. 2021, 4, 11428−11457. [Google Scholar] [CrossRef]
  135. Lee, K.X.; Shameli, K.; Yew, Y.P.; Teow, S.Y.; Jahangirian, H.; Rafiee-Moghaddam, R.; Webster, T.J. Recent Developments in the Facile Bio-Synthesis of Gold Nanoparticles (AuNPs) and Their Biomedical Applications. Int. J. Nanomed. 2020, 15, 275–300. [Google Scholar] [CrossRef] [PubMed]
  136. López, Y.C.; Antuch, M. Morphology control in the plant-mediated synthesis of magnetite nanoparticles. Curr. Opin. Green Sustain. Chem. 2020, 24, 32–37. [Google Scholar] [CrossRef]
  137. Soltys, L.; Olkhovyy, O.; Tatarchuk, T.; Naushad, M. Green Synthesis of Metal and Metal Oxide Nanoparticles: Principles of Green Chemistry and Raw Materials. Magnetochemistry 2021, 7, 145. [Google Scholar] [CrossRef]
  138. Yew, Y.P.; Shameli, K.; Miyake, M.; Kuwano, N.; Khairudin, N.B.B.A.; Mohamad, S.E.B.; Lee, K.X. Green synthesis of magnetite (Fe3O4) nanoparticles using seaweed (Kappaphycus alvarezii) extract. Nanoscale Res. Lett. 2016, 11, 1–7. [Google Scholar] [CrossRef] [Green Version]
  139. Nurbasa, M.; Ghorbanpoorb, H.; Avcic, H. An Eco-Friendly Approach to Synthesis and Characterization of Magnetite (Fe3O4) Nanoparticles Using Platanus orientalis, L. Leaf Extract Digest. J. Nanomater. Biostruct. 2017, 12, 993–1000. [Google Scholar]
  140. Kanagasubbulakshmi, S.; Kadirvelu, K. Green synthesis of Iron oxide nanoparticles using Lagenaria siceraria and evaluation of its Antimicrobial activity. Def. Life Sci. J. 2017, 2, 422–427. [Google Scholar] [CrossRef] [Green Version]
  141. Khana, T.; Ullah AliKhan, M.; Mashwani Akhtar Nadhman, Z.R. Plant-based gold nanoparticles; a comprehensive review of the decade-long research on synthesis, mechanistic aspects and diverse applications. Adv. Colloid Interface Sci. 2019, 272, 102017. [Google Scholar] [CrossRef]
  142. Rónavári, A.; Igaz, N.; Adamecz, D.I.; Szerencsés b Molnar, C.; Kónya, Z.; Pfeiffer, I.; Kiricsi, M. Green Silver and Gold Nanoparticles: Biological Synthesis Approaches and Potentials for Biomedical Applications. Molecules 2021, 26, 844. [Google Scholar] [CrossRef]
  143. Elia, P.; Zach, R.; Hazan, S.; Kolusheva, S.; Porat, Z.; Zeiri, Y. Green synthesis of gold nanoparticles using plant extracts as reducing agents. Int. J. Nanomed. 2014, 9, 4007–4021. [Google Scholar] [CrossRef] [Green Version]
  144. Gardea-Torresdey, J.L.; Gomez, E.; Peralta-Videa, J.R.; Parsons, J.G.; Troiani, H.; Jose-Yacaman, M. Alfalfa Sprouts: A Natural Source for the Synthesis of Silver Nanoparticles. Langmuir 2003, 19, 1357–1361. [Google Scholar] [CrossRef]
  145. Philip, D. Rapid green synthesis of spherical gold nanoparticles using Mangifera indica leaf. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2010, 77, 807–810. [Google Scholar] [CrossRef] [PubMed]
  146. Aljabali, A.A.A.; Akkam, Y.; Al Zoubi, M.S.; Al-Batayneh, K.M.; Al-Trad, B.; Alrob Alkilany, O.A.A.M.; Benamara, M.; Evansù, D.J. Synthesis of Gold Nanoparticles Using Leaf Extract of Ziziphus zizyphus and their Antimicrobial Activity. Nanomaterials 2018, 8, 174. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  147. Muniyappan, N.; Pandeeswaran, M.; Amalraj, A. Green synthesis of gold nanoparticles using Curcuma pseudomontana isolated Curcumin: Its characterization, antimicrobial, antioxidant and anti- inflammatory activities. Environ. Chem. Ecotoxicol. 2021, 3, 117–124. [Google Scholar] [CrossRef]
  148. Ahmad, N.; Sharma, A.K.; Sharma, S.; Khan, I.; Sharma, D.K.; Shamsi, A.; Santhosh Kumar, T.R.; Seervi, M. Biosynthesized composites of Au-Ag nanoparticles using Trapa peel extract induced ROS-mediated p53 independent apoptosis in cancer cells. Drug Chem. Toxicol. 2019, 42, 43–53. [Google Scholar] [CrossRef]
  149. Geethalakshmi, R.; Sarada, D.V.L. Gold and silver nanoparticles from Trianthema decandra: Synthesis, characterization, and antimicrobial properties. Int. J. Nanomed. 2012, 7, 5375–5384. [Google Scholar] [CrossRef] [Green Version]
  150. Yang, N.; WeiHong, L.; Hao, L. Biosynthesis of Au nanoparticles using agricultural waste mango peel extract and its in vitro cytotoxic effect on two normal cells. Mater. Lett. 2014, 34, 67–70. [Google Scholar] [CrossRef]
  151. Yew, Y.P.; Shameli, K.; Miyake, M.; Khairudin, N.B.A.; Mohamad, S.E.; Naiki, T.; XinLee, K. Green biosynthesis of superparamagnetic magnetite Fe3O4 nanoparticles and biomedical applications in targeted anticancer drug delivery system: A review. Arab. J. Chem. 2020, 13, 2287–2308. [Google Scholar] [CrossRef]
  152. Kemp, M.M.; Kumar, A.; Mousa, S.; Park, T.J.; Ajayan, P.; Kubotera, N.; Mousa, S.A.; Linhardy, R.J. Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecules 2009, 10, 589–595. [Google Scholar] [CrossRef]
  153. Kim, H.S.; Jun, S.H.; Koo, Y.K.; Cho, S.; Park, Y. Green synthesis and nanotopography of heparin-reduced gold nanoparticles with enhanced anticoagulant activity. J. Nanosci. Nanotechnol. 2013, 13, 2068–2076. [Google Scholar] [CrossRef]
  154. Gole, A.; Kumar, A.; Phadtare, S.; Mandale, A.B.; Sastry, M. Glucose induced in-situ reduction of chloroaurate ions entrapped in a fatty amine film: Formation of gold nanoparticle–lipid composites. PhysChemComm 2001, 4, 92–95. [Google Scholar] [CrossRef]
  155. Pinheiro, T.; Ferrão, J.; Marques, A.C.; Oliveira, M.J.; Batra, N.M.; Costa, P.M.F.J.; Macedo, M.P.; Águas, H.; Martins, R.; Fortunato, E. Paper-Based In-Situ Gold Nanoparticle Synthesis for Colorimetric, Non-Enzymatic Glucose. Nanomaterials 2020, 10, 2027. [Google Scholar] [CrossRef]
  156. Engelbrekt, C.; Sørensen, K.H.; Zhang, J.; Welinder, A.C.; Jensen, P.S.; Ulstrup, J. Green synthesis of gold nanoparticles with starch–glucose and application in bioelectrochemistry. J. Mater. Chem. 2009, 19, 7839–7847. [Google Scholar] [CrossRef]
  157. Park, J.; Cha, S.-H.; Cho, S.; Park, Y. Green synthesis of gold and silver nanoparticles using gallic acid: Catalytic activity and conversion yield toward the 4-nitrophenol reduction reaction. J. Nanoparticle Res. 2016, 18, 166. [Google Scholar] [CrossRef]
  158. Wang, W.; Chen, Q.; Jiang, C.; Yang, D. One-step synthesis of biocompatible gold nanoparticles using gallic acid in the presence of poly-(N-vinyl-2-pyrrolidone). Colloids Surf. A Physicochem. Eng. Asp. 2007, 301, 73–79. [Google Scholar] [CrossRef]
  159. Herrera-Becerra, R.; Rius, J.L.; Zorrilla, C. Tannin biosynthesis of iron oxide nanoparticles. Appl. Phys. A 2010, 100, 453–459. [Google Scholar] [CrossRef]
  160. Ahmad, T. Reviewing the Tannic Acid Mediated Synthesis of Metal Nanoparticles. J. Nanotechnol. 2014, 2014, 954206. [Google Scholar] [CrossRef] [Green Version]
  161. Devi, H.S.; Singh, T.D. Iron oxide nanoparticles synthesis through a benign approach and its catalytic application. Perspect. Sci. 2016, 8, 287–289. [Google Scholar] [CrossRef] [Green Version]
  162. Ponsanti, K.; Tangnorawich, B.; Ngernyuang, N.; Pechyen, C. A flower shape-green synthesis and characterization of silver nanoparticles (AgNPs) with different starch as a reducing agent. J. Mater. Res. Technol. 2020, 9, 11003–11012. [Google Scholar] [CrossRef]
  163. Chairam, S.; Konkamdee, W.; Parakhun, R. Starch-supported gold nanoparticles and their use in 4-nitrophenol reduction. J. Saudi Chem. Soc. 2017, 21, 656–663. [Google Scholar] [CrossRef]
  164. Lomelí-Marroquín, D.; Medina Cruz, D.; Nieto-Argüello, A.; Vernet Crua, A.; Chen, J.; Torres-Castro, A.; Webster, T.J.; Cholula-Díaz, J.L. Starch-mediated synthesis of mono- and bimetallic silver/gold nanoparticles as antimicrobial and anticancer agents. Int. J. Nanomed. 2019, 2019, 2171—2190. [Google Scholar] [CrossRef] [Green Version]
  165. Miola, M.; Multari, C.; Debellis, D.; Laviano, F.; Gerbaldo, R.; Vernè, E. Magneto-plasmonic heterodimers: Evaluation of different synthesis approaches. J. Am. Ceram. Soc. 2021, 105, 1276–1285. [Google Scholar] [CrossRef]
  166. Miola, M.; Vernè, E. In situ reduction of Ag on magnetic nanoparticles with gallic acid: Effect of the synthesis parameters on morphology. Nanomedicine 2022, 17, 499–511. [Google Scholar] [CrossRef] [PubMed]
  167. Saire-Saire, S.; Barbosa, E.C.M.; Garcia, D.; Andrade, D.; Garcia-Segura, S.; Camargo PHc Alarcon, H. Green synthesis of Au decorated CoFe2O4 nanoparticles for catalytic reduction of 4-nitrophenol and dimethylphenylsilane oxidation. RSC Adv. 2019, 9, 22116. [Google Scholar] [CrossRef] [Green Version]
  168. Izadiyana, Z.; Shamelia, Z.; Miyakea, M.; Teow, S.Y.; Pehb, S.C.; Mohamada, S.E.; Taiba, S.H.M. Green fabrication of biologically active magnetic core-shell Fe3O4/Au nanoparticles and their potential anticancer effect. Mater. Sci. Eng. C 2019, 96, 51–57. [Google Scholar] [CrossRef] [PubMed]
  169. Al din Haratifar, H.; Shahverdi, H.R.; Shakibaie, M.; Moghaddam, K.M.; Amini, M.; Montazeri, H.; Shahverdi, A.R. Semi-Biosynthesis of Magnetite-Gold Composite Nanoparticles Using an Ethanol Extract of Eucalyptus camaldulensis and Study of the Surface Chemistry, Hindawi Publishing Corporation. J. Nanomater. 2009, 2009, 962021. [Google Scholar] [CrossRef] [Green Version]
  170. Dizaji, A.N.; Yilmaz, M.; Piskin, E. Silver or gold deposition onto magnetite nanoparticles by using plant extracts as reducing and stabilizing agents. Artif. Cells Nanomed. Biotechnol. 2016, 44, 1109–1115. [Google Scholar] [CrossRef]
  171. Chin, S.F.; Lyer, K.S.; Raston, C.L. Facile and green approach to fabricate gold and silver coated superparamagnetic nanoparticles. Cryst. Growth Des. 2009, 9, 2685–2689. [Google Scholar] [CrossRef]
  172. Kokate, M.; Dapurkar, S.; Garadkar, K.; Gole, A. Magnetite−Silica−Gold Nanocomposite: One-Pot Single-Step Synthesis and Its Application for Solvent-Free Oxidation of Benzyl Alcohol. J. Phys. Chem. C 2015, 119, 14214−14223. [Google Scholar] [CrossRef]
  173. Narayanan, S.; Sathy, B.N.; Mony, U.; Koyakutty, M.; Nair, S.V.; Menon, D. Biocompatible Magnetite/Gold Nanohybrid Contrast Agents via Green Chemistry for MRI and CT Bioimaging. ACS Appl. Mater. Interfaces 2012, 4, 251−260. [Google Scholar] [CrossRef]
  174. Kadasala, N.R.; Lin, L.; Gilpi, C.; Wei, A. Eco-friendly (green) synthesis of magnetically active gold nanoclusters. Sci. Technol. Adv. Mater. 2017, 18, 210–218. [Google Scholar] [CrossRef]
Figure 1. Examples of iron oxide-gold nanostructures: (a) core-satellites with different structures (I–VI), (b) spherical core-shell with different structures (I–V), (c) non-spherical core-shell with different structures (I–VIII), (d) hollow structures.
Figure 1. Examples of iron oxide-gold nanostructures: (a) core-satellites with different structures (I–VI), (b) spherical core-shell with different structures (I–V), (c) non-spherical core-shell with different structures (I–VIII), (d) hollow structures.
Materials 15 07036 g001
Figure 2. Schematization of photothermal therapy application (a), magnetic hyperthermia (b), drug delivery and targeting (c), bioimaging (d) and SERS application, detection and separation (e).
Figure 2. Schematization of photothermal therapy application (a), magnetic hyperthermia (b), drug delivery and targeting (c), bioimaging (d) and SERS application, detection and separation (e).
Materials 15 07036 g002
Figure 3. (a) Magnetization curve at 300 K of the magnetic nanoparticles synthetized by Pseudomonas aeruginosa; (be) Magnetic analysis performed with four bacterial cells evidencing that nanoparticles had a small remanence and coercive fields; (f) Transmission electron microscopy images showing the pseudo spherical shape f three isolates; (g) The magnetic nanoparticles diameter (size) distribution obtained from the STEM images. Adapted with permission (Creative Commons CC BY license) from [100].
Figure 3. (a) Magnetization curve at 300 K of the magnetic nanoparticles synthetized by Pseudomonas aeruginosa; (be) Magnetic analysis performed with four bacterial cells evidencing that nanoparticles had a small remanence and coercive fields; (f) Transmission electron microscopy images showing the pseudo spherical shape f three isolates; (g) The magnetic nanoparticles diameter (size) distribution obtained from the STEM images. Adapted with permission (Creative Commons CC BY license) from [100].
Materials 15 07036 g003
Figure 4. Gold nanoparticles production using leaf extract of Ziziphus zizyphus: UV-Vis and TEM analysis. Adapted with permission (Creative Commons CC BY license) from [146].
Figure 4. Gold nanoparticles production using leaf extract of Ziziphus zizyphus: UV-Vis and TEM analysis. Adapted with permission (Creative Commons CC BY license) from [146].
Materials 15 07036 g004
Figure 5. STEM analysis of magnetite nanoparticles decorated with Au nanoparticles using tannic acid as reducing agent.
Figure 5. STEM analysis of magnetite nanoparticles decorated with Au nanoparticles using tannic acid as reducing agent.
Materials 15 07036 g005
Table 1. Fe3O4 and Au nanoparticles recently produced using microorganisms.
Table 1. Fe3O4 and Au nanoparticles recently produced using microorganisms.
NanoparticlesReducing AgentShape/DimensionReference
Fe3O4Proteus vulgarisSpherical/20–360 nm[98,99]
Fe3O4Pseudomonas aeruginosaSpherical/30–50 nm[100]
Fe3O4Thermoanaerobacter ethanolicusOctahedral/<12 nm[101]
Fe3O4Magnetospirillium magnetotacticumSpherical/<50 nm[101]
Fe3O4Fusarium oxysporumPseudo-spherical/20–50 nm[102]
Fe3O4Verticillium sp.Cubo-octahedral/100–400 nm[102]
Fe3O4Aspergillus nigerSpherical/18–50 nm[103]
AuCaldicellulosiruptor changbaiensisSpherical/20–60 nm[104]
AuShewanella loihicaSpherical/2–15 nm[105]
AuMicrococcus yunnanensisSpherical/15–55 nm[106]
AuStenotrophomonas maltophiliaSpherical/40 nm[107]
AuActinobacter spp.Triangular/50–60 nm[108]
AuRhodopseudomonasPyramidal/10–20 nmSpherical/10–20 nm[109,110]
AuP. aeruginosaSpherical/15–40 nm[111]
AuBacillus cerusSpherical, hexagonal, and octagonal/20–50 nm[112]
AuEscherichia coliSpherical/5–130 nm[99]
AuStreptomyces sp. VITDDK3Cubic/90 nm[113]
AuKlebsiella pneumoniaeSpherical/24–256 nm[99,114]
AuAlternaria alternateSpherical, triangular, hexagonal/12–29[115]
AuFusarium oxysporumSpherical/20–50 nmSpherical, hexagonal, and octagonal/20–50 nm[112,116]
AuT. koningiiSpherical/10–14 nm[117]
AuHormoconis resinaeSpherical/3–20 nm[118]
AuAureobasidium pullulans, Fusarium oxysporum and FusariumSpherical/23–35 nm[119]
AuPhanerochaete ChrysosporiumSpherical/10–100 nm[120]
AuBotrytis cinereaSpherical, triangular, hexagonal, decahedral, and pyramidal/1 to 100 nm.[121]
Table 2. Magneto-plasmonic heterostructures produced using green approaches.
Table 2. Magneto-plasmonic heterostructures produced using green approaches.
Reducing AgentShape/DimensionReference
Tannic acidDifferent nanostructures/-[11,165,166]
Juglans regiaCore-shell, spherical/6.08 ± 1.06 nm[168]
Eucalyptus camaldulensisNanocomposite, core-shell/6–20 nm[169]
Ligustrum vulgareCore-shell, spherical/10.1–12.1 nm[170]
GlucoseCore-shell, spherical/10–13 nm[171,172]
Grape seed proanthocyanidinSpherical/35 nm[173]
Amino acid l-histidineNanoclusters/<100 nm[174]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Miola, M.; Multari, C.; Vernè, E. Iron Oxide-Au Magneto-Plasmonic Heterostructures: Advances in Their Eco-Friendly Synthesis. Materials 2022, 15, 7036. https://0-doi-org.brum.beds.ac.uk/10.3390/ma15197036

AMA Style

Miola M, Multari C, Vernè E. Iron Oxide-Au Magneto-Plasmonic Heterostructures: Advances in Their Eco-Friendly Synthesis. Materials. 2022; 15(19):7036. https://0-doi-org.brum.beds.ac.uk/10.3390/ma15197036

Chicago/Turabian Style

Miola, Marta, Cristina Multari, and Enrica Vernè. 2022. "Iron Oxide-Au Magneto-Plasmonic Heterostructures: Advances in Their Eco-Friendly Synthesis" Materials 15, no. 19: 7036. https://0-doi-org.brum.beds.ac.uk/10.3390/ma15197036

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop